• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补充欧米伽-3脂肪酸可降低心肌梗死住院患者发生心房颤动的一年风险。

Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction.

作者信息

Macchia Alejandro, Monte Simona, Pellegrini Fabio, Romero Marilena, Ferrante Daniel, Doval Hernán, D'Ettorre Antonio, Maggioni Aldo Pietro, Tognoni Gianni

机构信息

Department of Clinical Pharmacology and Epidemiology, Santa Maria Imbaro, Chieti, Italy.

出版信息

Eur J Clin Pharmacol. 2008 Jun;64(6):627-34. doi: 10.1007/s00228-008-0464-z.

DOI:10.1007/s00228-008-0464-z
PMID:18309477
Abstract

PURPOSE

Current strategies for avoiding atrial fibrillation (AF) are of limited value. We aim to assess the relationship between omega-3 fatty acids (n-3 PUFA) and AF occurrence in post-myocardial infarction (MI) patients.

METHODS

A population study, linking hospital discharge records, prescription databases, and vital statistics, was conducted and included all consecutive patients with MI (ICD-9: 410) in six Italian local health authorities over a 3-year period. A propensity score (PS)-based, 5-to-1, greedy 1:1 matching algorithm was used to check consistency of results. Sensitivity analysis was performed to assess the robustness of findings.

RESULTS

N-3 PUFA reduced the relative risk of the hospitalization for AF [hazard ratio (HR) 0.19, 95% CI 0.07-0.51] and was associated with a further and complementary reduction in all-cause mortality (HR 0.15, 95% CI 0.05-0.46). PS-based matched analysis and sensitivity analysis confirmed the main results.

CONCLUSION

n-3 PUFA reduced both all-cause mortality and incidence of 1-year AF in patients hospitalized with MI.

摘要

目的

目前用于预防心房颤动(AF)的策略价值有限。我们旨在评估ω-3脂肪酸(n-3多不饱和脂肪酸)与心肌梗死(MI)后患者发生AF之间的关系。

方法

开展了一项基于人群的研究,该研究将医院出院记录、处方数据库和人口动态统计数据相联系,纳入了意大利六个地方卫生当局在3年期间内所有连续的MI患者(国际疾病分类第九版:410)。采用基于倾向评分(PS)的5比1贪婪1比1匹配算法来检验结果的一致性。进行敏感性分析以评估研究结果的稳健性。

结果

n-3多不饱和脂肪酸降低了AF住院的相对风险[风险比(HR)0.19,95%置信区间0.07 - 0.51],并与全因死亡率的进一步互补性降低相关(HR 0.15,95%置信区间0.05 - 0.46)。基于PS的匹配分析和敏感性分析证实了主要结果。

结论

n-3多不饱和脂肪酸降低了MI住院患者的全因死亡率和1年AF发病率。

相似文献

1
Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction.补充欧米伽-3脂肪酸可降低心肌梗死住院患者发生心房颤动的一年风险。
Eur J Clin Pharmacol. 2008 Jun;64(6):627-34. doi: 10.1007/s00228-008-0464-z.
2
Omega-3 fatty acid supplements and risk of atrial fibrillation and 'micro-atrial fibrillation': A secondary analysis from the OMEMI trial.ω-3 脂肪酸补充剂与心房颤动和“微心房颤动”风险:来自 OMEMI 试验的二次分析。
Clin Nutr. 2023 Sep;42(9):1657-1660. doi: 10.1016/j.clnu.2023.07.002. Epub 2023 Jul 19.
3
Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.ω-3 脂肪酸预防复发性有症状的心房颤动:FORWARD 试验(随机试验评估多不饱和脂肪酸在持续性心房颤动中维持窦性节律的疗效)的结果。
J Am Coll Cardiol. 2013 Jan 29;61(4):463-468. doi: 10.1016/j.jacc.2012.11.021. Epub 2012 Dec 19.
4
Omega-3 polyunsaturated Fatty acids reduce the incidence of postoperative atrial fibrillation in patients with history of prior myocardial infarction undergoing isolated coronary artery bypass grafting.ω-3多不饱和脂肪酸可降低既往有心肌梗死病史且接受单纯冠状动脉旁路移植术患者术后房颤的发生率。
Thorac Cardiovasc Surg. 2014 Oct;62(7):569-74. doi: 10.1055/s-0034-1371699. Epub 2014 Apr 22.
5
Fish oil and postoperative atrial fibrillation: the Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) randomized trial.鱼油与术后心房颤动:ω-3 脂肪酸预防术后心房颤动(OPERA)随机试验。
JAMA. 2012 Nov 21;308(19):2001-11. doi: 10.1001/jama.2012.28733.
6
A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation/atrial flutter-a Danish cohort study.海洋 n-3 脂肪酸摄入量与心房颤动/心房扑动发生之间的 U 型关联——一项丹麦队列研究
Europace. 2014 Nov;16(11):1554-61. doi: 10.1093/europace/euu019. Epub 2014 Feb 26.
7
The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation.ω-3脂肪酸在心房颤动管理中的当前作用
Int J Mol Sci. 2015 Sep 22;16(9):22870-87. doi: 10.3390/ijms160922870.
8
Prevention of postoperative atrial fibrillation in open heart surgery patients by preoperative supplementation of n-3 polyunsaturated fatty acids: an updated meta-analysis.术前补充 n-3 多不饱和脂肪酸预防心脏直视手术患者术后心房颤动:更新的荟萃分析。
J Thorac Cardiovasc Surg. 2013 Oct;146(4):906-11. doi: 10.1016/j.jtcvs.2013.03.015. Epub 2013 Apr 12.
9
Perioperative supplementation of polyunsaturated omega-3 fatty acid for the prevention of atrial fibrillation after cardiothoracic surgery.围手术期补充多不饱和ω-3脂肪酸预防心胸外科手术后房颤
Am J Health Syst Pharm. 2017 Jan 1;74(1):e17-e23. doi: 10.2146/ajhp150740. Epub 2016 Dec 22.
10
Fish, long-chain omega-3 polyunsaturated fatty acid intake and incidence of atrial fibrillation: A pooled analysis of two prospective studies.鱼类、长链 ω-3 多不饱和脂肪酸摄入与心房颤动发生率:两项前瞻性研究的汇总分析。
Clin Nutr. 2017 Apr;36(2):537-541. doi: 10.1016/j.clnu.2016.01.019. Epub 2016 Feb 3.

引用本文的文献

1
Unraveling the role of lactate-related genes in myocardial infarction.解析乳酸相关基因在心肌梗死中的作用。
Heliyon. 2024 Sep 19;10(18):e38152. doi: 10.1016/j.heliyon.2024.e38152. eCollection 2024 Sep 30.
2
Global Insights into Chronic Obstructive Pulmonary Disease and Coronary Artery Disease: A Systematic Review and Meta-Analysis of 6,400,000 Patients.慢性阻塞性肺疾病和冠状动脉疾病的全球洞察:对640万患者的系统评价和荟萃分析
Rev Cardiovasc Med. 2024 Jan 15;25(1):25. doi: 10.31083/j.rcm2501025. eCollection 2024 Jan.
3
Cancer Incidence and Mortality According to Pre-Existing Heart Failure in a Community-Based Cohort.

本文引用的文献

1
Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.根据近期心肌梗死患者的临床特征探讨n-3多不饱和脂肪酸的疗效:来自GISSI-Prevenzione试验的见解。
J Cardiovasc Med (Hagerstown). 2007 Sep;8 Suppl 1:S34-7. doi: 10.2459/01.JCM.0000289271.80180.b6.
2
The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure.慢性阻塞性肺疾病对因慢性心力衰竭住院患者的预后影响。
Eur J Heart Fail. 2007 Sep;9(9):942-8. doi: 10.1016/j.ejheart.2007.06.004. Epub 2007 Jul 12.
3
基于社区队列中既往存在的心力衰竭情况的癌症发病率和死亡率
JACC CardioOncol. 2022 Jan 18;4(1):98-109. doi: 10.1016/j.jaccao.2021.11.007. eCollection 2022 Mar.
4
Clinical Overview of Obesity and Diabetes Mellitus as Risk Factors for Atrial Fibrillation and Sudden Cardiac Death.肥胖与糖尿病作为心房颤动和心源性猝死危险因素的临床概述
Front Physiol. 2019 Jan 7;9:1847. doi: 10.3389/fphys.2018.01847. eCollection 2018.
5
DietaryFish and Long-Chain n-3 Polyunsaturated Fatty Acids Intake and Risk of Atrial Fibrillation: A Meta-Analysis.膳食鱼类和长链 n-3 多不饱和脂肪酸摄入与心房颤动风险:一项荟萃分析。
Nutrients. 2017 Aug 29;9(9):955. doi: 10.3390/nu9090955.
6
Do Omega-3 Fatty Acids Decrease the Incidence of Atrial Fibrillation?Omega-3脂肪酸能否降低心房颤动的发病率?
J Atr Fibrillation. 2013 Jun 30;6(1):836. doi: 10.4022/jafib.836. eCollection 2013 Jun-Jul.
7
Omega-3 Polyunsaturated Fatty Acid Supplementation: Mechanism and Current Evidence in Atrial Fibrillation.补充ω-3多不饱和脂肪酸:心房颤动的机制及当前证据
J Atr Fibrillation. 2012 Dec 16;5(4):718. doi: 10.4022/jafib.718. eCollection 2012 Dec.
8
Effect of Omega-3 Polyunsaturated Fatty Acid Supplementation in Patients with Atrial Fibrillation.补充omega-3多不饱和脂肪酸对心房颤动患者的影响。
J Atr Fibrillation. 2012 Aug 20;5(2):502. doi: 10.4022/jafib.502. eCollection 2012 Aug-Sep.
9
Omega 3 and atrial fibrillation: Where are we?欧米伽3与心房颤动:我们目前进展如何?
World J Cardiol. 2016 Feb 26;8(2):114-9. doi: 10.4330/wjc.v8.i2.114.
10
The Current Role of Omega-3 Fatty Acids in the Management of Atrial Fibrillation.ω-3脂肪酸在心房颤动管理中的当前作用
Int J Mol Sci. 2015 Sep 22;16(9):22870-87. doi: 10.3390/ijms160922870.
Antithrombotic treatment is strongly underused despite reducing overall mortality among high-risk elderly patients hospitalized with atrial fibrillation.
Eur Heart J. 2006 Sep;27(18):2217-23. doi: 10.1093/eurheartj/ehl208. Epub 2006 Aug 25.
4
Rationale and design of the GISSI-Atrial Fibrillation Trial: a randomized, prospective, multicentre study on the use of valsartan, an angiotensin II AT1-receptor blocker, in the prevention of atrial fibrillation recurrence.GISSI-心房颤动试验的原理与设计:一项关于使用血管紧张素II AT1受体阻滞剂缬沙坦预防心房颤动复发的随机、前瞻性、多中心研究。
J Cardiovasc Med (Hagerstown). 2006 Jan;7(1):29-38. doi: 10.2459/01.JCM.0000199778.85343.08.
5
Intake of very long-chain n-3 fatty acids from fish and incidence of atrial fibrillation. The Rotterdam Study.鱼类中极长链n-3脂肪酸的摄入与心房颤动的发生率。鹿特丹研究。
Am Heart J. 2006 Apr;151(4):857-62. doi: 10.1016/j.ahj.2005.07.029.
6
N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial.N-3脂肪酸预防冠状动脉搭桥术后房颤:一项随机对照试验。
J Am Coll Cardiol. 2005 May 17;45(10):1723-8. doi: 10.1016/j.jacc.2005.02.079.
7
Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: results from the Valsartan Heart Failure Trial (Val-HeFT).缬沙坦降低心力衰竭患者心房颤动的发生率:缬沙坦心力衰竭试验(Val-HeFT)的结果。
Am Heart J. 2005 Mar;149(3):548-57. doi: 10.1016/j.ahj.2004.09.033.
8
Non-antiarrhythmic drugs to prevent atrial fibrillation.预防心房颤动的非抗心律失常药物。
Heart Rhythm. 2004 Oct;1(4):516-8. doi: 10.1016/j.hrthm.2004.02.019.
9
Advances in antiarrhythmic drug treatment of atrial fibrillation: where do we stand now?心房颤动抗心律失常药物治疗的进展:我们目前处于什么阶段?
Heart Rhythm. 2004 Jul;1(2):244-6. doi: 10.1016/j.hrthm.2004.02.023.
10
Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis.心房颤动患者的心率控制与节律控制:一项荟萃分析。
Arch Intern Med. 2005 Feb 14;165(3):258-62. doi: 10.1001/archinte.165.3.258.